Clinical Trial

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Safety and pharmacokinetic characteristics evaluation of DW4421-T1 and DW4421S-T1
Trial Details
NCT Number NCT07364851
Lead Sponsor Daewon Pharmaceutical Co., Ltd.
Conditions Healthy Adult Volunteer
Enrollment 38 participants
Start Date 2026-03-06
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-23